Novoprotein Scientific Inc.

Novoprotein Scientific Inc. (Novoprotein) is a high-tech enterprise with more than 10 years of extensive experience in the recombinant protein industry, focusing on protein technology, and advanced in R&D, production, sales, and application solutions to raw materials and techniques for biopharmaceuticals, in vitro diagnosis, mRNA vaccines, and basic life science research. Our principal products include target proteins and cytokines, recombinant antibodies, molecular enzymes and reagents, as well as providing related technical services. Novoprotein possesses R&D and manufacturing bases in Shanghai, Suzhou, and Heze.

We have developed more than ten thousand of recombinant proteins and have independently researched and developed 7 comprehensive technology platforms and 23 core technologies, including protein design and modification, protein production and quality control, and protein application and evaluation. Novoprotein provides biomedical Industry customers with one-stop services from product development to technological innovation on the basis of a comprehensive technology system and in-house innovative raw materials.